Duke University School of Medicine

I said, I don't see it that way.

I said, because when I'm in my own clinic and I got a patient scheduled for 15 minutes, I said, this is Duke University School of Medicine.

So we're supposed to teach medical students.

Right.

You know, it took me forever.

I went to Duke Medical School.

That's where my degree is from.

So I fully believed in allopathic medicine up to COVID.

It's not very little, actually.

Just reading through this, he's a graduate of Duke University Medical School.

He's a board certified in internal medicine.

He was in private practice in affiliation with John Muir Medical School in San Francisco Bay Area for more than 30 years.

I'm really excited to be here.

So I am an associate professor of psychiatry and behavioral sciences at Duke University School of Medicine, and I'm a clinical psychologist by training.

So my areas of expertise specifically focus on sleep and how sleep relates to mental health conditions in children and adolescents.

And what excites me most about science is discovery.

Are we over-diagnosing them? Are we under-diagnosing them? If we're diagnosing them properly, are we treating them properly? Well, there's a bit of news that seems to indicate that AI can be useful in this, in this, uh, area and possibly scan medical records in order to spot the risk in children years earlier than they're actually diagnosed.

Now, that study was led by our next guest, Dr. Matthew Engelhard, who is an MD-PhD, no slouch there, Assistant Professor of Biostatistics at the Duke University School of Medicine, and he's developing these new AI methods in order to create data to support accurate diagnoses in our kids.

Hello, Dr. Engelhard.

Welcome to The Last Show.

Wild, wild stuff.

That same fellow is now doing a quarterly CPC thing at Duke University Medical School.

See what I'm talking about? A group, God knows what kind of talent you've got in it.

But if it's just a one-dimensional thing where I just go in there and feed, feed, feed me, and never find a way to open that channel and let my contributions come out, wither and die, won't you? It won't last very long.

Dr. Sharif is the director of the Duke Onco Endocrinology Program and an associate director of for the Cancer Therapy Toxicity Program at Duke Center for Cancer Immunotherapy.

She holds a faculty appointment as an Associate Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism at Duke University School of Medicine.

Her clinical work and research are focused on high value care for endocrine disease like diabetes in cancer patients.

Dr. Sharif, thanks so much for being here.

It's very complicated.

I have, you know, many colleagues at Duke Med now.

My family always said, "Why didn't you go make the big bucks? You have always been a government lawyer." [laughs] But those kinds of, uh, litigation cases are very complicated because it's hard to prove.

You know, um, it's, it's hard to prove that somebody wasn't doing better on drugs that have helped so many others.